Prognostic Value of Biomarkers in RCC

Video

Robert Alter, MD opines on the current prognostic value of biomarkers for RCC and the need for additional data in the field.

Recent Videos
Given resource scarcity, developing practice strategies for resource-constrained settings would require aid from commercial and government stakeholders.
Large international meetings may facilitate conversations regarding disparities of care outside of high-income countries.
Observing changes in the tumor microenvironment before and after a biopsy may elucidate how kidney cancer cells interact with immune cells.
Related Content